Related references
Note: Only part of the references are listed.Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer
Thomas Benjamin Davis et al.
CANCERS (2022)
MEK inhibitor resistance mechanisms and recent developments in combination trials
E. Kun et al.
CANCER TREATMENT REVIEWS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma
Hongxin Cao et al.
ONCOLOGY LETTERS (2021)
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
G. Emerens Wensink et al.
NPJ PRECISION ONCOLOGY (2021)
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Ensembl 2021
Kevin L. Howe et al.
NUCLEIC ACIDS RESEARCH (2021)
Biomarker-guided therapy for colorectal cancer: strength in complexity
Anita Sveen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The Human Gene Mutation Database (HGMD(R)): optimizing its use in a clinical diagnostic or research setting
Peter D. Stenson et al.
HUMAN GENETICS (2020)
Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges
Joyce Y. Buikhuisen et al.
ONCOGENESIS (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
Dirk Schumacher et al.
PLOS GENETICS (2019)
Targeting mTOR for cancer therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread
E. Pretzsch et al.
JOURNAL OF ONCOLOGY (2019)
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
Ilya G. Serebriiskii et al.
NATURE COMMUNICATIONS (2019)
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas
Ariel L. Hernandez et al.
MOLECULAR CARCINOGENESIS (2019)
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Nhan Phan et al.
COMMUNICATIONS BIOLOGY (2019)
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
Marella D. Canny et al.
NATURE BIOTECHNOLOGY (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2
Qingyu Luo et al.
CANCER LETTERS (2018)
The role of TGF-beta/SMAD4 signaling in cancer
Ming Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
New Trends in the Therapeutic Approach to Metastatic Colorectal Cancer
Julia Sanchez-Gundin et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
Qiang Wang et al.
CELL DEATH & DISEASE (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Prediction of Colorectal Cancer Driver Genes from Patients' Genome Data
Muhammad-Iqmal Abdullah et al.
SAINS MALAYSIANA (2018)
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
Radhika Mathur et al.
NATURE GENETICS (2017)
From tumour heterogeneity to advances in precision treatment of colorectal cancer
Cornelis J. A. Punt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer
Shazia Irshad et al.
JOURNAL OF PATHOLOGY (2017)
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
Moritz Schuette et al.
NATURE COMMUNICATIONS (2017)
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
Claudio Isella et al.
NATURE COMMUNICATIONS (2017)
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer
Soulafa Mamlouk et al.
NATURE COMMUNICATIONS (2017)
PIK3CA mutation and colorectal cancer precision medicine
Tsuyoshi Hamada et al.
Oncotarget (2017)
Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells
Mateusz Opyrchal et al.
ONCOTARGET (2017)
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Amir Mehrvarz Sarshekeh et al.
PLOS ONE (2017)
Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway
Eiji Sakai et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The BMP Signaling Pathway Leads to Enhanced Proliferation in Serous Ovarian Cancer-A Potential Therapeutic Targetf
Jin Peng et al.
MOLECULAR CARCINOGENESIS (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
GOexpress: an R/Bioconductor package for the identification and visualisation of robust gene ontology signatures through supervised learning of gene expression data
Kevin Rue-Albrecht et al.
BMC BIOINFORMATICS (2016)
A bead-based western for high-throughput cellular signal transduction analyses
Fridolin Treindl et al.
NATURE COMMUNICATIONS (2016)
Role of Biologics in First-Line Treatment of Colorectal Cancer
Amit Mahipal et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients
Laura Lupini et al.
BMC CANCER (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Data quality aware analysis of differential expression in RNA-seq with NOISeq R/Bioc package
Sonia Tarazona et al.
NUCLEIC ACIDS RESEARCH (2015)
FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15
Ningning Li et al.
ONCOTARGET (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation
Md Shaifur Rahman et al.
BONE RESEARCH (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
The emerging roles of ARID1A in tumor suppression
Ren-Chin Wu et al.
CANCER BIOLOGY & THERAPY (2014)
Personalized Dosing via Pharmacokinetic Monitoring of 5-Fluorouracil Might Reduce Toxicity in Early- or Late-Stage Colorectal Cancer Patients Treated With Infusional 5-Fluorouracil-Based Chemotherapy Regimens
Christina Leah B. Kline et al.
CLINICAL COLORECTAL CANCER (2014)
The Biology and Clinical Development of MEK Inhibitors for Cancer
Jason J. Luke et al.
DRUGS (2014)
Loss of SMAD4 Alters BMP Signaling to Promote Colorectal Cancer Cell Metastasis via Activation of Rho and ROCK
Philip W. Voorneveld et al.
GASTROENTEROLOGY (2014)
Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
Yoshihito Yokoyama et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2014)
Acquired resistance to EGFR-targeted therapies in colorectal cancer
Beth O. Van Emburgh et al.
MOLECULAR ONCOLOGY (2014)
The clinical development of MEK inhibitors
Yujie Zhao et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
Sandra Misale et al.
CANCER DISCOVERY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
V. Eklof et al.
BRITISH JOURNAL OF CANCER (2013)
SMAD2, SMAD3 and SMAD4 Mutations in Colorectal Cancer
Nicholas I. Fleming et al.
CANCER RESEARCH (2013)
Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma
Lei He et al.
CANCER DISCOVERY (2013)
Software for Computing and Annotating Genomic Ranges
Michael Lawrence et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Xiaoyun Liao et al.
CLINICAL CANCER RESEARCH (2012)
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
Panagiotis Papageorgis et al.
CANCER RESEARCH (2011)
ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
Bin Guan et al.
CANCER RESEARCH (2011)
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Jonathan R. Dry et al.
CANCER RESEARCH (2010)
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance
Masaaki Iwatsuki et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients
Ying Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation
M. T. Bengoechea-Alonso et al.
ONCOGENE (2010)
A scaling normalization method for differential expression analysis of RNA-seq data
Mark D. Robinson et al.
GENOME BIOLOGY (2010)
The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers
Liudmila L. Kodach et al.
GASTROENTEROLOGY (2008)
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
Ludovic Barault et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
Bone morphogenetic protein signalling in colorectal cancer
James C. Hardwick et al.
NATURE REVIEWS CANCER (2008)
Human gene mutation database (HGMD®):: 2003 update
PD Stenson et al.
HUMAN MUTATION (2003)
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
JL Boulay et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
